KIRKLAND, Wash.--(BUSINESS WIRE)--Pathway Medical Technologies, Inc., a wholly owned subsidiary of MEDRAD, Inc. - a Business of Bayer Healthcare, today announced initiation of the JET Registry, a national registry focused on tracking patients with symptomatic peripheral arterial disease (PAD) undergoing percutaneous interventions. The JET Registry will enroll up to 500 patients at approximately 75 clinical sites across the United States. Patients will be followed for up to one year post treatment. The first patient was enrolled this month with Dr. Vinay Kumar at South Central Regional Medical Center in Laurel, Mississippi.
